Zevra Therapeutics: Miplyffa Uptake Validates Rare Disease Commercial Model
Source: SeekingAlpha
2026-03-10 10:52:52 ET
Thesis
Read the full article on Seeking Alpha
For further details see:
Zevra Therapeutics: Miplyffa Uptake Validates Rare Disease Commercial Model
Zevra Therapeutics Inc.
NASDAQ: ZVRA
ZVRA Trading
-8.38% G/L:
$9.90 Last:
1,761,155 Volume:
$10.76 Open:
ZVRA Latest News
ZVRA Stock Data
$484,721,776
54,946,394
0.39%
48
N/A
Biotechnology & Life Sciences
Healthcare
US
Celebration
